Hermetica Superfood Encyclopedia
The Short Answer
Araujia sericifera contains triterpenes (lupeol, germanicol and their esters) and polar alkaloids including trigonelline and serotonin, which have been identified via GC-MS and NMR analysis of leaf, stem, and fruit extracts, though their molecular targets in human disease remain uncharacterized. No clinical trials have established efficacy or safe dosing for any indication, including the Zulu traditional use for amafufunyana (psychotic depression), and the plant is documented as a medium-severity poison with CNS-toxic seeds.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAraujia sericifera medicinal uses
Araujia sericifera — botanical close-up
Health Benefits
**Traditional Emetic Action**
Araujia sericifera has been historically employed as an emetic in southern African folk medicine; the mechanism is uncharacterized at a molecular level, but may involve irritant alkaloids or serotonin-related gastrointestinal stimulation present in leaf and fruit extracts.
**Analgesic Properties (Traditional)**
Older ethnobotanical reports attribute analgesic properties to the plant; lupeol, a triterpene identified in nonpolar hexanic extracts, is documented in the broader scientific literature to modulate prostaglandin synthesis and inflammatory mediators, though this has not been tested directly in Araujia sericifera preparations.
**Anti-inflammatory Potential**
Germanicol-3-acetate and lupeol-3-cinnamate, two predominant triterpen-3-ol esters in leaf extracts, belong to compound classes with established in vitro NF-κB and COX pathway inhibitory activity in other botanical species; no direct testing in this plant has confirmed these pathways.
**Antihistaminic Effects (Traditional)**
Traditional use as an antihistaminic agent has been reported in ethnobotanical literature, possibly linked to the serotonin and luteolin-7-glucoside identified in methanolic fruit and leaf extracts, both of which interact with histamine and inflammatory signaling in other research contexts.
**In Vitro Cytotoxic Activity**
Crude extracts of Araujia sericifera have been screened against cancer cell lines and demonstrated cytotoxic potential in preliminary in vitro assays; the responsible phytochemicals and specific mechanisms have not been isolated or quantified, and no in vivo or clinical translation has occurred.
**Ethnopsychiatric Use for Amafufunyana**
In Zulu traditional medicine, plant-derived preparations have been used as part of treatment protocols for amafufunyana (a culturally defined syndrome encompassing psychotic depression, aggression, and spirit possession, also called iQuwa); this use lacks pharmacological or clinical validation, and the serotonin and trigonelline content raises hypothetical relevance to monoaminergic pathways without evidence of therapeutic effect.
Origin & History
Natural habitat
Araujia sericifera is native to South America, particularly Argentina, Bolivia, and southern Brazil, where it grows in subtropical and temperate regions with disturbed soils, roadsides, and forest margins. The plant has been widely introduced and naturalized across southern Africa, southern Europe, Australia, and parts of Asia, where it is classified as an invasive weed due to its aggressive vine growth and prolific seed dispersal via wind-borne silky tufts. It is not intentionally cultivated as a medicinal crop; rather, traditional use in southern African contexts draws upon feral, opportunistically harvested plant material from naturalized populations.
“In southern African ethnomedicine, particularly within Zulu healing traditions, Araujia sericifera has been associated with the treatment of amafufunyana, a culturally recognized syndrome characterized by psychotic features, aggression, involuntary vocalizations, and perceived spirit possession, sometimes equated with acute psychotic depression or dissociative episodes in biomedical frameworks. Traditional healers (izinyanga and izangoma) incorporate a range of plant materials into complex multiherbal preparations for such conditions, and Araujia sericifera's role, if any, is as one component among many rather than a singular therapeutic agent. The plant's South American origin means it has no deep pre-colonial history in African traditional medicine; its use likely developed after naturalization of the invasive vine in South Africa, and documentation in the ethnobotanical literature remains sparse and lacking in preparation detail. Historically, emetic plants hold significant ritual and purgative roles in many southern African healing systems, where induced vomiting is considered spiritually and physically purifying, which may explain the initial incorporation of this plant given its documented emetic properties.”Traditional Medicine
Scientific Research
The scientific evidence base for Araujia sericifera as a medicinal ingredient is extremely limited and of low quality, consisting primarily of phytochemical characterization studies using GC-MS and NMR spectroscopy on aerial plant parts and one or more preliminary in vitro cytotoxicity screens on cancer cell lines, with no quantitative outcomes published. No controlled animal studies, pharmacokinetic investigations, or human clinical trials of any phase have been identified in the peer-reviewed literature; the plant's research profile is dominated by its ecology, invasive weed management, and phytopathological studies of fungal pathogens rather than therapeutic investigation. The phytochemical work, while identifying a relevant suite of bioactive compound classes (triterpenoids, flavonoid glycosides, alkaloids), does not report tissue concentrations, extraction yields, or bioactive thresholds necessary for dose-response modeling. Given this landscape, any medicinal or nutritional claims must be regarded as ethnobotanically derived hypotheses awaiting rigorous preclinical and clinical investigation.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Unvalidated)**
Aerial plant parts (leaves, stems) prepared as water-based decoctions for traditional emetic or ethnopsychiatric use in southern African contexts; no standardized preparation method, plant-part ratio, or volume has been documented in scientific literature.
**Methanolic Extract (Research Grade Only)**
Polar methanolic extraction of leaves and fruits used in laboratory phytochemical and cytotoxicity studies; not available as a consumer supplement and not appropriate for human self-administration.
**Hexanic Extract (Research Grade Only)**
Nonpolar hexanic extraction yields triterpenoid-rich fractions from fruits and leaves; used exclusively in laboratory contexts with no established therapeutic dose.
**No Established Therapeutic Dose**
No safe or effective human dose has been determined for any form of this plant; the absence of pharmacokinetic data and the documented medium-severity toxicity of seeds and whole plant preclude dose recommendation.
**Standardization**
No commercial standardized extract exists; no reference standard concentrations for lupeol, germanicol, trigonelline, or other key compounds have been published for therapeutic preparations.
Nutritional Profile
Araujia sericifera has not been subjected to formal nutritional analysis, and no macronutrient, micronutrient, or caloric content data are available in the scientific literature. Phytochemical profiling of leaf and fruit extracts identifies luteolin-7-glucoside (a flavonoid glycoside with antioxidant properties), serotonin, conduritol F (a cyclitol with potential glucosidase-inhibitory activity), virbutinol, trigonelline, lupeol, germanicol, lupeol-3-cinnamate, and germanicol-3-acetate as notable non-nutritive bioactive constituents; precise tissue concentrations for none of these have been quantified in published studies. The plant is not recognized as a food source, and its medium-severity toxicity classification, particularly the CNS-toxic seed fraction, renders it unsuitable as a nutritional ingredient. Bioavailability of any identified compound from whole-plant preparations is entirely unknown due to the absence of pharmacokinetic research.
How It Works
Mechanism of Action
The postulated mechanistic basis for Araujia sericifera's traditional actions remains largely speculative and inferred from compound class literature rather than direct experimental investigation. Lupeol and germanicol, the principal triterpene alcohols in nonpolar leaf extracts, are known in other systems to suppress NF-κB transcriptional activity and reduce prostaglandin E2 production by inhibiting COX-2 enzyme expression, offering a plausible but unverified anti-inflammatory and analgesic mechanism. The presence of serotonin in methanolic leaf and fruit extracts raises the theoretical possibility of serotonergic activity at 5-HT receptors relevant to mood and gastrointestinal motility, which could partially underlie traditional emetic and ethnopsychiatric applications; however, oral bioavailability of plant-derived serotonin is negligible under normal gastrointestinal conditions. Trigonelline, an alkaloid abundant in the leaves, is documented in other contexts to modulate nicotinic acetylcholine receptors and influence glucose metabolism via AMPK activation, but no pathway-level investigation has been conducted for Araujia sericifera extracts specifically, and the CNS-toxic properties attributed to seeds suggest the presence of uncharacterized neurotoxic constituents that complicate any therapeutic interpretation.
Clinical Evidence
There are no published clinical trials evaluating Araujia sericifera for any health indication, including its primary traditional use in the management of amafufunyana or iQuwa in Zulu ethnomedicine. No human cohort studies, observational data with quantified outcomes, or animal efficacy models with measured endpoints have been reported in accessible scientific databases as of the most recent literature review. The sole experimental data involving biological activity consists of unquantified in vitro cytotoxicity screening on cancer cell lines, which cannot be extrapolated to clinical effect sizes, therapeutic windows, or safety margins in humans. Confidence in any clinical benefit is therefore negligible from an evidence-based medicine perspective, and the ingredient should be treated as a subject of ethnopharmacological inquiry rather than an evidence-supported therapeutic agent.
Safety & Interactions
Araujia sericifera is classified as a medium-severity poison, with seeds specifically documented to exert toxic effects on the central nervous system; whole-plant exposure may cause poisoning, and emetic effects have been historically reported following ingestion, indicating significant gastrointestinal irritancy at undetermined doses. No systematic adverse event surveillance, dose-toxicity relationships, or NOAEL (No Observed Adverse Effect Level) data have been established for any plant part or extract fraction, making it impossible to define a margin of safety for therapeutic use. No drug interactions have been formally documented; however, the presence of serotonin-related compounds and CNS-active constituents raises theoretical concern for interactions with monoamine oxidase inhibitors, serotonergic antidepressants, and anticonvulsant medications, and these combinations should be regarded as potentially hazardous in the absence of interaction data. Use during pregnancy and lactation is contraindicated on precautionary grounds given the documented toxicity profile, complete absence of reproductive safety data, and the plant's status as a recognized poison rather than a food-grade or pharmaceutical-grade botanical.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Araujia sericifera Brot.White bladderflowerMoth vineCruel vineKapok vine
Frequently Asked Questions
Is Araujia sericifera safe to use as a herbal remedy?
Araujia sericifera is classified as a medium-severity poison, with seeds specifically documented to be toxic to the central nervous system and whole-plant exposure capable of causing poisoning. No safe human dose has been established, no pharmacokinetic studies exist, and it is not recognized as a food-grade or pharmaceutical botanical; its use as a self-administered herbal remedy carries unquantified but real toxicity risk and cannot be recommended.
What is Araujia sericifera used for in Zulu traditional medicine?
In Zulu traditional healing, Araujia sericifera is associated with the treatment of amafufunyana (also called iQuwa), a culturally defined syndrome involving psychotic features, involuntary behaviors, and perceived spirit possession that overlaps conceptually with psychotic depression in biomedical terms. Its inclusion in traditional formulations likely relates to its documented emetic properties, as induced vomiting holds ritualistic and purgative significance in many southern African healing systems, though no scientific studies have validated its efficacy for this or any other indication.
What bioactive compounds are found in Araujia sericifera?
Phytochemical analysis using GC-MS and NMR has identified lupeol, germanicol, lupeol-3-cinnamate, and germanicol-3-acetate as principal triterpenoids in nonpolar hexanic extracts of leaves and fruits, while polar methanolic extracts yield luteolin-7-glucoside, trigonelline, serotonin, conduritol F, and virbutinol. Trigonelline is particularly abundant in leaves, and serotonin and luteolin-7-glucoside are found in fruits, but no tissue concentration data have been quantified in published studies.
Are there any clinical trials on Araujia sericifera?
No clinical trials of any phase have been conducted on Araujia sericifera for any health condition, and no controlled animal efficacy studies with measured outcomes have been published either. The only experimental biological data available are unquantified in vitro cytotoxicity screens on cancer cell lines, which represent the lowest tier of preclinical evidence and cannot be used to infer human therapeutic effects, effective doses, or safety margins.
Why is Araujia sericifera considered an invasive weed rather than a medicinal plant?
Araujia sericifera originates from South America and has naturalized aggressively across southern Africa, Australia, southern Europe, and parts of Asia, where it outcompetes native vegetation, entangles and kills pollinating moths (trapping them in its flowers), and spreads rapidly via wind-dispersed seeds with silky tufts. Scientific and regulatory attention has focused almost entirely on its ecological harm and weed management rather than medicinal potential, and the plant is not cultivated or commercialized as a therapeutic ingredient in any recognized herbal medicine system.
What is the difference between Araujia sericifera leaf extract and fruit extract for traditional use?
Both leaf and fruit extracts of Araujia sericifera have been used in southern African traditional medicine, but fruit extracts are historically more associated with emetic properties, while leaf extracts are referenced in analgesic applications. The bioactive alkaloid concentrations and serotonin-related compounds may vary between plant parts, potentially affecting the intensity and type of gastrointestinal or pain-relief response. No direct comparative studies have been published to establish which form is more effective or bioavailable.
Who should avoid Araujia sericifera due to its emetic properties?
Pregnant women, individuals with gastrointestinal disorders (such as ulcers or inflammatory bowel conditions), and those with cardiovascular sensitivity should avoid Araujia sericifera, particularly given its historical use as a strong emetic and uncharacterized alkaloid profile. Elderly persons and children lack adequate safety data and should not use this ingredient without direct medical supervision. Anyone taking medications that affect serotonin or gastrointestinal function should consult a healthcare provider before use.
How does the bioavailability of Araujia sericifera extracts compare between oral and other traditional preparation methods?
Traditional preparation methods in southern African folk medicine primarily involved oral ingestion of leaf and fruit decoctions or extracts, though specific bioavailability data for this ingredient is not published in peer-reviewed literature. The irritant alkaloids and putative serotonin-active compounds present in Araujia sericifera extracts may have variable absorption rates depending on extraction method, solvent type, and individual digestive factors. No comparative studies on bioavailability between preparation methods (decoction vs. tincture vs. dried powder) have been conducted for this species.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w araujia-sericifera-white-bladderflower-moth-vine curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
